BrainStorm Cell Therapeutics, Inc. (BCLI.OB) Enters Agreement for Adult Stem Cell Production
BrainStorm Cell Therapeutics Inc. is a company developing adult stem cell therapeutic products, derived from autologous (self) bone marrow cells, for the treatment of neurodegenerative diseases. The technology allows for the differentiation of bone marrow-derived stem cells into functional neurons and astrocytes. BrainStorm Cell Therapeutics is currently focusing its technology on two diseases – Parkinson's and ALS, which is also known as Lou Gehrig's disease. The company announced today that it has entered into an agreement with Protein Production Services Ltd., a leading manufacturing contractor, in order to start “good manufacturing practice” production of its stem cell therapeutic product. The…